vs
Side-by-side financial comparison of Elme Communities (ELME) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
Elme Communities is the larger business by last-quarter revenue ($62.1M vs $31.1M, roughly 2.0× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -198.9%, a 166.8% gap on every dollar of revenue. On growth, Elme Communities posted the faster year-over-year revenue change (1.7% vs -4.5%). Elme Communities produced more free cash flow last quarter ($7.2M vs $25.0K). Over the past eight quarters, Elme Communities's revenue compounded faster (2.7% CAGR vs -0.1%).
Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
ELME vs LFCR — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $31.1M |
| Net Profit | $-123.5M | $-10.0M |
| Gross Margin | 61.1% | 25.0% |
| Operating Margin | -183.3% | -9.9% |
| Net Margin | -198.9% | -32.1% |
| Revenue YoY | 1.7% | -4.5% |
| Net Profit YoY | -4058.7% | -52.0% |
| EPS (diluted) | $-1.40 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $62.1M | $31.1M | ||
| Q2 25 | $62.1M | — | ||
| Q1 25 | $61.5M | $35.2M | ||
| Q4 24 | $61.3M | $32.6M | ||
| Q3 24 | $61.1M | $24.7M | ||
| Q2 24 | $60.1M | — | ||
| Q1 24 | $59.5M | $35.7M | ||
| Q4 23 | $58.9M | $30.1M |
| Q3 25 | $-123.5M | $-10.0M | ||
| Q2 25 | $-3.6M | — | ||
| Q1 25 | $-4.7M | $-14.8M | ||
| Q4 24 | $-3.0M | $-6.6M | ||
| Q3 24 | $-3.0M | $-16.2M | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $-3.6M | $15.6M | ||
| Q4 23 | $-3.1M | $14.2M |
| Q3 25 | 61.1% | 25.0% | ||
| Q2 25 | 63.5% | — | ||
| Q1 25 | 64.2% | 28.0% | ||
| Q4 24 | 62.9% | 34.0% | ||
| Q3 24 | 63.5% | 21.8% | ||
| Q2 24 | 63.4% | — | ||
| Q1 24 | 63.5% | 33.3% | ||
| Q4 23 | 65.6% | 33.0% |
| Q3 25 | -183.3% | -9.9% | ||
| Q2 25 | 9.6% | — | ||
| Q1 25 | 7.8% | -25.7% | ||
| Q4 24 | 10.4% | -6.0% | ||
| Q3 24 | 11.0% | -46.9% | ||
| Q2 24 | 9.8% | — | ||
| Q1 24 | 7.5% | -2.5% | ||
| Q4 23 | 10.7% | -4.9% |
| Q3 25 | -198.9% | -32.1% | ||
| Q2 25 | -5.7% | — | ||
| Q1 25 | -7.6% | -42.0% | ||
| Q4 24 | -4.9% | -20.2% | ||
| Q3 24 | -4.9% | -65.7% | ||
| Q2 24 | -5.8% | — | ||
| Q1 24 | -6.1% | 43.8% | ||
| Q4 23 | -5.3% | 47.2% |
| Q3 25 | $-1.40 | $-0.29 | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $-0.05 | $-0.47 | ||
| Q4 24 | $-0.04 | $-0.25 | ||
| Q3 24 | $-0.03 | $-0.53 | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.04 | $0.42 | ||
| Q4 23 | $-0.04 | $0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $908.9M | $-10.5M |
| Total Assets | $1.7B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $7.1M | $18.9M | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $6.4M | $5.4M | ||
| Q4 24 | $6.1M | $9.5M | ||
| Q3 24 | $4.8M | — | ||
| Q2 24 | $5.6M | — | ||
| Q1 24 | $4.2M | — | ||
| Q4 23 | $6.0M | — |
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M | ||
| Q4 23 | — | $92.9M |
| Q3 25 | $908.9M | $-10.5M | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.1B | $2.2M | ||
| Q4 24 | $1.1B | $15.4M | ||
| Q3 24 | $1.1B | $-3.9M | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | $17.7M | ||
| Q4 23 | $1.2B | $1.4M |
| Q3 25 | $1.7B | $235.2M | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | $237.7M | ||
| Q4 24 | $1.8B | $255.4M | ||
| Q3 24 | $1.9B | $246.8M | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.9B | $246.2M | ||
| Q4 23 | $1.9B | $245.8M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× | ||
| Q4 23 | — | 65.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.9M | $1.8M |
| Free Cash FlowOCF − Capex | $7.2M | $25.0K |
| FCF MarginFCF / Revenue | 11.6% | 0.1% |
| Capex IntensityCapex / Revenue | 14.0% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $86.7M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $15.9M | $1.8M | ||
| Q2 25 | $29.8M | — | ||
| Q1 25 | $16.2M | $1.2M | ||
| Q4 24 | $95.2M | $-6.1M | ||
| Q3 24 | $20.7M | $-613.0K | ||
| Q2 24 | $28.9M | — | ||
| Q1 24 | $21.2M | $-1.4M | ||
| Q4 23 | $22.9M | $1.3M |
| Q3 25 | $7.2M | $25.0K | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $10.5M | $-4.3M | ||
| Q4 24 | $47.9M | $-8.6M | ||
| Q3 24 | $8.8M | $-4.0M | ||
| Q2 24 | $21.0M | — | ||
| Q1 24 | $7.6M | $-7.8M | ||
| Q4 23 | $6.9M | $-3.0M |
| Q3 25 | 11.6% | 0.1% | ||
| Q2 25 | 34.1% | — | ||
| Q1 25 | 17.1% | -12.1% | ||
| Q4 24 | 78.1% | -26.3% | ||
| Q3 24 | 14.4% | -16.3% | ||
| Q2 24 | 34.9% | — | ||
| Q1 24 | 12.8% | -21.8% | ||
| Q4 23 | 11.8% | -9.9% |
| Q3 25 | 14.0% | 5.6% | ||
| Q2 25 | 14.0% | — | ||
| Q1 25 | 9.2% | 15.5% | ||
| Q4 24 | 77.4% | 7.5% | ||
| Q3 24 | 19.4% | 13.9% | ||
| Q2 24 | 13.1% | — | ||
| Q1 24 | 22.9% | 17.8% | ||
| Q4 23 | 27.1% | 14.1% |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× | ||
| Q4 23 | — | 0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
